Kfar Saba, Israel

Michal Harel

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Oncohost Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michal Harel. Retrieved from https://idiyas.com/inventor/michal-harel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Michal Harel: Revolutionizing Cancer Treatment

Introduction: Michal Harel, an accomplished inventor based in Kfar Saba, Israel, has made significant strides in the field of cancer treatment through his innovative approach. With a focus on identifying therapeutic agents that effectively target cancer, Harel’s contributions are paving the way for more personalized and effective cancer therapies.

Latest Patents: Harel holds a notable patent titled "Cancer Process Evaluation," which outlines methods for selecting therapeutic agents to treat cancer in a subject. This groundbreaking patent involves the receipt of protein data element values representing protein levels in a biological sample. The process includes classifying each protein into process classes, calculating a process score that indicates the relevance of these classes to cancer treatment resistance, and subsequently selecting therapeutic agents that target processes based on these scores. The patent also includes systems designed for the selection of these therapeutic agents, showcasing a novel method in oncology.

Career Highlights: As an integral member of Oncohost Ltd., Michal Harel's expertise lies in bridging the gap between molecular biology and clinical applications. His work is crucial in advancing the understanding of how different proteins interact with cancer treatment protocols, potentially leading to improved outcomes for patients through tailored therapies.

Collaborations: Harel collaborates with talented colleagues such as Eyal Jacob and Ben Yellin, who contribute their skills and insights to further the innovative projects at Oncohost Ltd. Together, they are dedicated to enhancing cancer therapies and making substantial impacts in the medical field.

Conclusion: Michal Harel's inventive spirit and commitment to cancer research exemplify the potential of innovation in medicine. Through his patent and collaborative efforts at Oncohost Ltd., Harel is not only advancing cancer treatment options but also inspiring future generations of inventors and researchers in the healthcare industry. The journey of Harel highlights the importance of innovation in addressing some of the most pressing challenges in medical science today.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…